Dr. Rishi Chadha, MD is a board‑certified gastroenterologist who specializes in preventive gastroenterology, colorectal cancer screening, and minimally invasive endoscopic procedures. He completed his fellowship at Sunrise Health GME in Las Vegas and previously trained in internal medicine at St. Vincent’s Medical Center in Connecticut.
Primary biliary cirrhosis (also called primary biliary cholangitis) is a chronic liver condition in which the immune system progressively destroys the small bile ducts inside the liver. Bile buildup damages liver cells over time, leading to scarring (cirrhosis). The ICD-10 code for this disease is K74.3.
He reviews your symptoms, personal and family history of liver or autoimmune disease, and performs a physical exam to look for signs like jaundice or liver enlargement.
He checks liver enzyme levels, bilirubin, and anti-mitochondrial antibodies (AMA) to detect autoimmune activity targeting the bile ducts.
This non-invasive scan measures liver stiffness, helping gauge the extent of fibrosis or early cirrhosis.
In selected cases, a small tissue sample confirms the diagnosis, stages the disease, and rules out other liver conditions.
Dr. Rishi Chadha, MD is a board‑certified gastroenterologist who specializes in preventive gastroenterology, colorectal cancer screening, and minimally invasive endoscopic procedures. He completed his fellowship at Sunrise Health GME in Las Vegas and previously trained in internal medicine at St. Vincent’s Medical Center in Connecticut.
Tiredness, mild itching, and dry eyes. Some people have no symptoms early on.
Blood tests, imaging (ultrasound or MRCP), liver stiffness test, and sometimes a biopsy.
No. A good diet supports the liver but doesn-t reverse scarring.
It improves bile flow and slows disease progress.
Yes. Obeticholic acid and newer drugs in clinical trials are showing good results.
If you have abnormal liver tests, itching, or fatigue that won-t go away.
Genes play a part, but it's not inherited directly like some diseases.
It is the code doctors and insurance use to label this liver disease.
Yes. Many people manage symptoms and live well with proper care.
In late stages, if medications stop working or complications arise.
